IRIS
VESPASIANI GENTILUCCI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.085
NA - Nord America 3.179
EU - Europa 1.445
SA - Sud America 595
AF - Africa 82
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.414
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 7.435
US - Stati Uniti d'America 3.050
CN - Cina 1.175
HK - Hong Kong 811
IT - Italia 639
BR - Brasile 418
VN - Vietnam 267
GB - Regno Unito 206
FR - Francia 202
DE - Germania 127
IN - India 101
AR - Argentina 64
MX - Messico 59
CA - Canada 51
ID - Indonesia 46
FI - Finlandia 44
NL - Olanda 43
BD - Bangladesh 37
EC - Ecuador 34
TR - Turchia 34
UA - Ucraina 29
ZA - Sudafrica 29
CZ - Repubblica Ceca 28
PL - Polonia 27
AU - Australia 25
JP - Giappone 22
ES - Italia 20
PK - Pakistan 18
SA - Arabia Saudita 18
IQ - Iraq 16
PH - Filippine 16
CO - Colombia 15
PY - Paraguay 15
RU - Federazione Russa 15
CL - Cile 14
VE - Venezuela 13
MY - Malesia 12
PE - Perù 11
SE - Svezia 11
EG - Egitto 9
UZ - Uzbekistan 9
CH - Svizzera 8
MA - Marocco 8
NP - Nepal 6
TH - Thailandia 6
TN - Tunisia 6
BO - Bolivia 5
ET - Etiopia 5
JM - Giamaica 5
KE - Kenya 5
LB - Libano 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BG - Bulgaria 4
BH - Bahrain 4
DZ - Algeria 4
IE - Irlanda 4
IL - Israele 4
OM - Oman 4
SY - Repubblica araba siriana 4
AO - Angola 3
AT - Austria 3
AZ - Azerbaigian 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IR - Iran 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
LT - Lituania 3
LU - Lussemburgo 3
NI - Nicaragua 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
IS - Islanda 2
JO - Giordania 2
MD - Moldavia 2
ME - Montenegro 2
MN - Mongolia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TL - Timor Orientale 2
XK - ???statistics.table.value.countryCode.XK??? 2
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
Totale 15.397
Salva come PNG Salva come JPEG
Città #
San Jose 1.037
Hong Kong 800
Singapore 796
Ashburn 703
Rome 524
Hefei 392
Beijing 287
Boardman 217
Dallas 180
Lauterbourg 172
London 158
Shanghai 137
Ho Chi Minh City 93
Los Angeles 66
Munich 62
Council Bluffs 60
Santa Clara 55
Hanoi 51
São Paulo 48
San Francisco 46
Mexico City 43
New York 35
Seattle 32
Brno 28
Pune 27
Turku 27
Guangzhou 25
Amsterdam 24
Warsaw 23
West Jordan 22
Toronto 21
Rio de Janeiro 20
Tokyo 20
Helsinki 17
Montreal 17
Washington 17
Chennai 16
Guayaquil 16
Boston 14
Da Nang 13
Haiphong 13
Orem 13
Canberra 12
Johannesburg 12
Frankfurt am Main 11
Sona 11
Manchester 10
Paris 10
Riyadh 10
Stockholm 10
Brasília 9
Lahore 9
Shenzhen 9
Brooklyn 8
Curitiba 8
New Delhi 8
Quito 8
Atlanta 7
Chicago 7
Hải Dương 7
Melbourne 7
Tashkent 7
Zhengzhou 7
Biên Hòa 6
Buenos Aires 6
Charlotte 6
Kuala Lumpur 6
Lima 6
Mumbai 6
Redmond 6
Sydney 6
Thái Bình 6
Thái Nguyên 6
Belo Horizonte 5
Belém 5
Buffalo 5
Cairo 5
Campinas 5
Caracas 5
Istanbul 5
Jakarta 5
Kyiv 5
Medellín 5
Milan 5
Nuremberg 5
Poplar 5
Ribeirão Preto 5
Secaucus 5
Shijiazhuang 5
Addis Ababa 4
Ankara 4
Bangkok 4
Bengaluru 4
Bologna 4
Can Tho 4
Cape Town 4
Central 4
Colombo 4
Delhi 4
Denver 4
Totale 6.738
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 246
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 243
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 239
Advances in management of periprosthetic joint infections: an historical prospective study 235
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 225
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 224
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 223
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 222
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 221
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 220
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 217
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 216
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 213
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 213
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 212
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 212
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 211
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 210
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 207
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 204
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 204
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 203
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 200
Assessment of liver function by the exhaled breath-print during chronic liver disease 200
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 155
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 151
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 132
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 130
[A 73-year-old woman with vomiting and metabolic alkalosis] 130
Diabetes in chronic liver disease: from old concepts to new evidence 130
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 129
A challenging alfa-fetoprotein in a cirrhotic patient 126
GH-resistance in different stages of chronic liver disease 126
[A 61-year-old woman with abdominal pain and urination disorders] 124
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 123
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 120
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 117
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 116
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 115
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 111
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 109
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 109
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 107
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 107
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 106
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 106
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 103
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 103
Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists 101
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 100
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 96
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 93
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 87
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 87
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 80
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 76
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 73
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 73
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 66
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 65
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 63
Pain and Frailty in Hospitalized Older Adults 63
TNF-alpha and growth hormone resistance in patients with chronic liver disease 62
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 62
Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation 61
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice 61
Reelin expression in human liver of patients with chronic hepatitis C infection 60
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 59
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis 58
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 58
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 57
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 56
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 56
Identification of matrix metalloprotease 10 (mmp10) as a key new mediator of the regenerative response of the liver 56
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 56
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 55
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development 54
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 54
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 53
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 53
Identification of Fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure 53
Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis 53
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 53
What changed in the Italian internal medicine and geriatric wards during the lockdown 53
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 52
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 51
Matrix metalloproteinase-10 contributes to hepatocellular carcinoma development in a novel crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis 51
Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma 51
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 51
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 50
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 50
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 50
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 50
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale 50
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 49
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 49
Totale 11.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 2 8 0 3 3 2 6 46 4 4 258
2022/2023112 12 1 6 4 10 2 30 4 3 5 33 2
2023/2024636 26 50 18 62 61 269 2 37 8 40 20 43
2024/20258.381 131 57 236 45 110 186 143 34 482 562 3.017 3.378
2025/20266.027 620 332 457 810 255 354 1.755 409 534 501 0 0
Totale 15.492